A prospective study of L‐DOPA/Istradefylline combination therapy, evaluating the glycolytic energy homeostasis in Parkinson's disease and to effects of Parkinson's disease pharmacotherapies on glycolytic dynamics
Latest Information Update: 22 Oct 2020
At a glance
- Drugs Istradefylline (Primary) ; Levodopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 22 Oct 2020 New trial record
- 16 Sep 2020 Results presented at the 24th International Congress of Parkinson's Disease and Movement Disorders